Table 5. Clinical characteristics of PRAD cohort with specification by age groups.
Age group | ||||
---|---|---|---|---|
≤50 | 51–60 | 61–70 | 70> | |
Characteristics | total | total | total | total |
Age at diagnosis | ||||
median (range) | 48 (41–50) | 56 (51–60) | 65 (61–70) | 72 (70–78) |
Pre-operative PSA | ||||
median (range) | 6.8 (0.8–107) | 7.6 (1.7–96.4) | 7.35 (0.7–87) | 9.45 (1.7–45) |
Gleason score | ||||
2+4 | - | - | - | 1 |
3+3 | 7 | 23 | 11 | 3 |
3+4 | 13 | 63 | 60 | 10 |
4+3 | 6 | 33 | 57 | 5 |
8≥ | 9 | 69 | 109 | 18 |
Tumor cellularity (pathology) | ||||
<20% | 1 | 6 | 5 | - |
21–40% | 4 | 8 | 12 | 3 |
41–60% | 9 | 50 | 84 | 10 |
61–80% | 12 | 88 | 99 | 17 |
81–100% | 8 | 29 | 31 | 5 |
NA | 1 | 7 | 6 | 2 |
PSA recurrence | ||||
yes | 3 | 21 | 34 | - |
no | 27 | 141 | 174 | 29 |
NA | 5 | 26 | 29 | 8 |